Search

everythinglearnresearchcommunity

for

Search:↓

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Proper education can prevent traction alopecia in women of color.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Some skin lymphomas can look like common skin issues and need careful testing to diagnose correctly.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Hydroxychloroquine may help treat alopecia areata in children.

Illness perception affects mental health and quality of life in Chinese alopecia patients.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

A child was initially wrongly diagnosed with a fungal scalp infection but actually had a non-scarring hair loss condition called Temporal Triangular Alopecia.

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

LALPS causes non-scarring hair loss along the Blaschko line, with unique trichoscopic findings.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.

Zinc helps manage skin disorders and deficiencies can worsen some conditions.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.